← FDA Drug Approvals (Drugs@FDA)
ACETAMINOPHEN, ASPIRIN AND CAFFEINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-02-02
Drug application
- FDA Application #
ANDA211695- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- Generic name
- ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- Active ingredients
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Amazon.com Services LLC
- First approval
- 2022-02-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown